After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Relay Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Relay Therapeutics Inc is $603.49M. A total of 1.14 million shares were traded on the day, compared to an average of 2.22M shares.
In the most recent transaction, Rahmer Peter sold 10,739 shares of RLAY for 3.00 per share on Apr 30 ’25. After the transaction, the insider now owns 390,081 company shares. In a previous transaction on Apr 28 ’25, Rahmer Peter sold 1,364 shares at 3.17 per share. RLAY shares that the insider owns now total 400,820.
Among the insiders who sold shares, Catinazzo Thomas disposed of 12,943 shares on Apr 30 ’25 at a per-share price of $3.00. This resulted in the Chief Financial Officer holding 355,376 shares of RLAY after the transaction. In another insider transaction, Catinazzo Thomas sold 3,558 shares at $3.23 per share on Apr 29 ’25. Company shares held by the Chief Financial Officer now total 368,319.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RLAY has a high of $10.72 and a low of $1.77.
As of this writing, RLAY has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.53.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $4.23, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.69.
